Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

CORDIS reúne toda la información sobre los proyectos financiados por Horizonte 2020 , y ahora también resúmenes de los informes relacionados. Se puede descargar toda la documentación de estos proyectos en el Portal de datos abiertos de la UE .

My refinements


Download results of this page


Restringir por:

Tipo de contenido

Proyecto (39)

Advanced search

Búsqueda de proyectos y resultados

Results 1 - 10 of 39
Results/page:
12 3 4 > 
SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
ID: 731875
Fecha de inicio: 2017-01-01, Fecha de finalización: 2021-12-31
Liver cirrhosis is a very common chronic disease and one of the leading causes of death in European. Moreover, cirrhosis has a marked impact in patients quality of life and represents a major burden for health systems. Treatment of cirrhosis is currently based on symptomatic...
Programme: H2020-EU.3.1.3.
Record Number: 207204
Last updated on: 2017-06-02
EURopean Endeavour for Chimeric Antigen Receptor Therapies
ID: 733297
Fecha de inicio: 2017-01-01, Fecha de finalización: 2020-12-31
Cancer is rapidly becoming the most frequent cause of death in EU. Though enormously expensive (several billions EUR/year), currently available anti-cancer therapies are major causes of chronic diseases. Adoptive immunotherapy with T cells genetically modified with a...
Programme: H2020-EU.3.1.3.
Record Number: 207227
Last updated on: 2017-01-26
Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory anginaA phase II randomized, double-blinded, placebo-controlled study
ID: 731532
Fecha de inicio: 2017-01-01, Fecha de finalización: 2021-06-30
Chronic angina pectoris is a debilitating chronic disease, a subgroup of these patients suffers from refractory angina which unfortunately can’t be controlled by medical therapy (angioplasty or surgery). Refractory angina is a substantial burden on the individual and...
Programme: H2020-EU.3.1.3.
Record Number: 207197
Last updated on: 2017-05-23
Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)
ID: 733057
Fecha de inicio: 2017-01-01, Fecha de finalización: 2020-09-30
Liver disease incidence is increasing and about 170K patients die from liver failure each year in Europe. In liver failure, the accumulation of protein bound toxins and increased susceptibility to infection cause multiorgan failure and death. Liver transplantation is the only...
Programme: H2020-EU.3.1.3.
Record Number: 207215
Last updated on: 2017-08-04
Transcranial brain stimulation as innovative therapy for chronic pediatric neuropsychiatric disorder – STIPED
ID: 731827
Fecha de inicio: 2017-01-01, Fecha de finalización: 2021-12-31
Due to lack of targeted interventions, compliance issues, insufficient effect sizes and a high non-responder rate to currently available interventions, there is an urgent need to develop innovative and new interventions for chronic paediatric neuropsychiatric disorders, such...
Programme: H2020-EU.3.1.3.
Record Number: 207203
Last updated on: 2017-08-17
Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial
ID: 733379
Fecha de inicio: 2017-01-01, Fecha de finalización: 2021-12-31
Ischemic stroke (IS), caused by occlusion of arteries that supply blood to the brain, remains a leading cause of mortality and morbidity in the world. Disruption of blood and oxygen supply to the brain leads to neuronal death in the ischemic core within minutes. The...
Programme: H2020-EU.3.1.3.
Record Number: 207449
Last updated on: 2017-05-23
Normothermic perfusion devices for renal and hepatic preservation and viability assessment
ID: 729703
Fecha de inicio: 2016-05-01, Fecha de finalización: 2016-10-31
Organ transplantation is the best available technique for the treatment of end-stage failure of most essential organs. However, the further development of transplantation is being hampered by the scarcity of available organs and the limitations of static cold preservation:...
Programme: H2020-EU.3.1.3.
Record Number: 204321
Last updated on: 2017-01-18
Clinical Validation of a Novel Biomarker for the Prediction of Bone Metastasis in Early Stage Breast and Prostate Cancer
ID: 719912
Fecha de inicio: 2016-03-01, Fecha de finalización: 2016-08-31
OSTEOMET is a new and proprietary test based on IHC and FISH technologies that addresses the unmet medical need of selecting patients at risk of bone metastasis in breast and prostate cancer. OSTEOMET is based on an innovative single biomarker whose expression levels in...
Programme: H2020-EU.3.1.3.
Record Number: 201788
Last updated on: 2016-02-26
Heart monitoring and early assistance in high risk crisis without patient intervention (COPCAR)
ID: 717805
Fecha de inicio: 2016-04-01, Fecha de finalización: 2016-09-30
Cardiovascular diseases (CVDs) are the main cause of death in Europe according the European Heart Network. The reaction time when first symptoms are detected is crucial to ensure the survival probability of the patient. In fact, delays in attending people who is suffering a...
Programme: H2020-EU.3.1.3.
Record Number: 201723
Last updated on: 2016-03-14
Nanofiber based drug delivery for surgical therapy of adult and paediatric solid tumours
ID: 762948
Fecha de inicio: 2017-02-01, Fecha de finalización: 2017-07-31
Cebiotex is a company founded by medical business entrepreneurs plus experts from the biomedical nano-fibre plus oncology sectors. With experts from a world leading hospital in cancer treatment(Sant Joan de Déu) and researchers from the Universitat Politecnica de Catalunya...
Programme: H2020-EU.3.1.3.
Record Number: 208009
Last updated on: 2017-02-01
12 3 4 > 
List retrieved on: 2018-06-19
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba